7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $428M | -$21M | 69.7% | -3.1% | $14M | $55M | $105M |
| 2024 | $305M | -$52M | 63.6% | -7.6% | -$34M | $56M | $85M |
| 2023 | $203M | -$176M | 44.4% | -89.2% | -$185M | $56M | $100M |
| 2022 | $235M | -$549M | -11.4% | -284.5% | -$326M | $11M | $124M |
| 2021 | $212M | -$245M | -7.8% | -210.3% | -$200M | $11M | $401M |
| 2020 | $179M | -$241M | 2.2% | -134.9% | -$117M | $21M | $108M |
| 2019 | $196M | -$30M | 42.2% | -15.5% | -$31M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $102M | -$63M | 66.7% | -56.2% | -$39M | $100M | $94M |
| Dec '25 | $121M | -$18M | 69.6% | -11.8% | -$7M | $55M | $105M |
| Sep '25 | $117M | -$8M | 72.4% | -2.8% | $10M | $55M | $96M |
| Jun '25 | $103M | $11M | 69.0% | 8.7% | $8M | $55M | $74M |
| Mar '25 | $87M | -$7M | 67.1% | -5.2% | $4M | $55M | $100M |
| Dec '24 | $96M | $5M | 69.2% | 9.2% | -$6M | $56M | $85M |
| Sep '24 | $77M | -$8M | 62.2% | -10.1% | -$5M | $56M | $58M |
| Jun '24 | $71M | -$29M | 60.9% | -15.0% | -$6M | $56M | $56M |
| Mar '24 | $62M | -$20M | 59.9% | -21.9% | -$17M | $56M | $84M |
| Dec '23 | $57M | -$26M | 53.6% | -44.7% | -$32M | $56M | $100M |
| Sep '23 | $53M | -$42M | 47.4% | -80.6% | -$41M | $6M | $87M |
| Jun '23 | $49M | -$47M | 38.5% | -106.0% | -$56M | $6M | $157M |
| Mar '23 | $43M | -$61M | 35.3% | -139.9% | -$56M | $6M | $202M |
| Dec '22 | $61M | -$309M | -26.6% | -529.6% | -$67M | $11M | $124M |
| Sep '22 | $83M | -$78M | 16.3% | -109.1% | -$91M | $11M | $191M |
| Jun '22 | $36M | -$86M | -81.8% | -449.7% | -$86M | $11M | $285M |
| Mar '22 | $54M | -$77M | 10.4% | -165.6% | -$83M | $11M | $315M |
| Dec '21 | $58M | -$40M | -4.9% | -200.3% | -$57M | $11M | $401M |
| Sep '21 | $43M | $33M | -19.2% | -204.4% | -$72M | $11M | $461M |
| Jun '21 | $47M | -$46M | -2.5% | -96.7% | -$27M | $18M | $27M |
How the market has priced WGSWW against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, GeneDx Holdings Corp.'s revenue has grown 19.0% per year. These are computed facts, not advice.
As of FY2025, GeneDx Holdings Corp. reported $55M of total debt against $105M of cash.
In FY2025, gross margin was 69.7%, operating margin -3.1%, and net margin -4.9%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.